- Page 1 and 2: OPERATIONAL PLAN FOR COMPREHENSIVE
- Page 3 and 4: LIST OF TABLES Table 0.1: Total Pro
- Page 5 and 6: LIST OF ACRONYMS ADR AIDS ALT API A
- Page 7 and 8: Foreword I would like to thank the
- Page 9 and 10: We hope that all South Africans who
- Page 11 and 12: 16. Dr. Fazel Randera, Health Advis
- Page 13 and 14: Executive Summary BACKGROUND 1. The
- Page 15 and 16: 6. Following the discussion of this
- Page 17 and 18: health status and to prolong life),
- Page 19 and 20: extreme inequalities and disparitie
- Page 21 and 22: 9.5 Providing a Comprehensive Conti
- Page 23 and 24: efforts through additional investme
- Page 25 and 26: elements in a containment strategy
- Page 27 and 28: 18. The programme detailed in this
- Page 29 and 30: monitoring of patients for TB, a co
- Page 31 and 32: 40 The drug procurement strategies
- Page 33 and 34: follow-up and monitoring for patien
- Page 35: CHAPTER III - TRADITIONAL MEDICINE
- Page 39 and 40: 85. Task Team projections of AIDS p
- Page 41 and 42: patented and/or branded drugs suppl
- Page 43 and 44: 102. It proposes a significant expa
- Page 45 and 46: measure the outcomes of the program
- Page 47 and 48: 119. Examples of specific research
- Page 49 and 50: Table 0.1: Total Programme Budget E
- Page 51 and 52: the existing health care system and
- Page 53 and 54: Table 0.2: New Patients Starting AR
- Page 55 and 56: DRAFT - Confidential Chapter I Prev
- Page 57 and 58: DRAFT - Confidential The key preven
- Page 59 and 60: DRAFT - Confidential practitioners,
- Page 61 and 62: DRAFT - Confidential 6. Levels of C
- Page 63 and 64: DRAFT - Confidential Patients seen
- Page 65 and 66: DRAFT - Confidential c. Adult ARV D
- Page 67 and 68: DRAFT - Confidential increased freq
- Page 69 and 70: DRAFT - Confidential first few week
- Page 71 and 72: DRAFT - Confidential development of
- Page 73 and 74: DRAFT - Confidential evidence, nevi
- Page 75 and 76: DRAFT - Confidential their lives. A
- Page 77 and 78: DRAFT - Confidential point of conta
- Page 79 and 80: DRAFT - Confidential ADMINISTRATIVE
- Page 81 and 82: DRAFT - Confidential joint collabor
- Page 83 and 84: DRAFT - Confidential reduces the po
- Page 85 and 86: DRAFT - Confidential Coordination w
- Page 87 and 88:
DRAFT - Confidential Chapter III Tr
- Page 89 and 90:
DRAFT - Confidential In addition to
- Page 91 and 92:
DRAFT - Confidential Development of
- Page 93 and 94:
DRAFT - Confidential SPECIAL CONSID
- Page 95 and 96:
DRAFT - Confidential SECTION TWO HU
- Page 97 and 98:
DRAFT - Confidential collaboration
- Page 99 and 100:
DRAFT - Confidential effectiveness)
- Page 101 and 102:
DRAFT - Confidential 18. A system i
- Page 103 and 104:
DRAFT - Confidential Chapter V Huma
- Page 105 and 106:
DRAFT - Confidential • ARV treatm
- Page 107 and 108:
DRAFT - Confidential Table 5.3: Cor
- Page 109 and 110:
DRAFT - Confidential Table 5.5: Tot
- Page 111 and 112:
DRAFT - Confidential forward, the e
- Page 113 and 114:
DRAFT - Confidential The general ch
- Page 115 and 116:
DRAFT - Confidential • ARV treatm
- Page 117 and 118:
DRAFT - Confidential Human Resource
- Page 119 and 120:
DRAFT - Confidential met. These bur
- Page 121 and 122:
DRAFT - Confidential capacity in ma
- Page 123 and 124:
DRAFT - Confidential will be streng
- Page 125 and 126:
DRAFT - Confidential 4. Explore cha
- Page 127 and 128:
DRAFT - Confidential ADMINISTRATIVE
- Page 129 and 130:
DRAFT - Confidential Chapter VI PRO
- Page 131 and 132:
DRAFT - Confidential Table 6.3 list
- Page 133 and 134:
DRAFT - Confidential Laboratories N
- Page 135 and 136:
DRAFT - Confidential Table 6.1: Fac
- Page 137 and 138:
DRAFT - Confidential Table 6.2: Pro
- Page 139 and 140:
DRAFT - Confidential prevalences, t
- Page 141 and 142:
DRAFT - Confidential Table 6.3: Sit
- Page 143 and 144:
DRAFT - Confidential SECTION THREE
- Page 145 and 146:
DRAFT - Confidential generic produc
- Page 147 and 148:
DRAFT - Confidential Fourthly, the
- Page 149 and 150:
DRAFT - Confidential Security of Su
- Page 151 and 152:
DRAFT - Confidential SPECIAL CONSID
- Page 153 and 154:
DRAFT - Confidential manufacturer.
- Page 155 and 156:
DRAFT - Confidential • Management
- Page 157 and 158:
DRAFT - Confidential delivery, the
- Page 159 and 160:
DRAFT - Confidential Pharmacies at
- Page 161 and 162:
DRAFT - Confidential • The Pharma
- Page 163 and 164:
DRAFT - Confidential as a contingen
- Page 165 and 166:
DRAFT - Confidential the first five
- Page 167 and 168:
DRAFT - Confidential • Improving
- Page 169 and 170:
DRAFT - Confidential Johannesburg.
- Page 171 and 172:
DRAFT - Confidential Infant diagnos
- Page 173 and 174:
DRAFT - Confidential SECTION FOUR C
- Page 175 and 176:
DRAFT - Confidential Chapter X Soci
- Page 177 and 178:
DRAFT - Confidential • Clear guid
- Page 179 and 180:
DRAFT - Confidential communities, a
- Page 181 and 182:
DRAFT - Confidential Care and Suppo
- Page 183 and 184:
DRAFT - Confidential The communicat
- Page 185 and 186:
DRAFT - Confidential SECTION FIVE I
- Page 187 and 188:
DRAFT - Confidential The systems sh
- Page 189 and 190:
DRAFT - Confidential and location o
- Page 191 and 192:
DRAFT - Confidential should enable
- Page 193 and 194:
DRAFT - Confidential The Cluster of
- Page 195 and 196:
DRAFT - Confidential or services. O
- Page 197 and 198:
DRAFT - Confidential Monitoring of
- Page 199 and 200:
DRAFT - Confidential The majority o
- Page 201 and 202:
DRAFT - Confidential Comparable rol
- Page 203 and 204:
DRAFT - Confidential Chapter XIII P
- Page 205 and 206:
DRAFT - Confidential drug-food inte
- Page 207 and 208:
DRAFT - Confidential Antimicrobial
- Page 209 and 210:
DRAFT - Confidential PROGRAMME ASSE
- Page 211 and 212:
DRAFT - Confidential agenda: to con
- Page 213 and 214:
DRAFT - Confidential South African
- Page 215 and 216:
DRAFT - Confidential AIDS in South
- Page 217 and 218:
DRAFT - Confidential There has been
- Page 219 and 220:
DRAFT - Confidential • What is th
- Page 221 and 222:
DRAFT - Confidential HIV infection
- Page 223 and 224:
DRAFT - Confidential • Determinat
- Page 225 and 226:
DRAFT - Confidential Research Overs
- Page 227 and 228:
DRAFT - Confidential SECTION SIX MA
- Page 229 and 230:
DRAFT - Confidential continual revi
- Page 231 and 232:
DRAFT - Confidential The work of th
- Page 233 and 234:
DRAFT - Confidential Figure 15.3: C
- Page 235 and 236:
DRAFT - Confidential continuous pro
- Page 237 and 238:
DRAFT - Confidential Finally, mecha
- Page 239 and 240:
DRAFT - Confidential protocols. The
- Page 241 and 242:
DRAFT - Confidential Table 16.1: Es
- Page 243 and 244:
DRAFT - Confidential required for t
- Page 245 and 246:
DRAFT - Confidential and consumable
- Page 247 and 248:
DRAFT - Confidential will also allo
- Page 249 and 250:
DRAFT - Confidential Table 16.8: Pl
- Page 251 and 252:
DRAFT - Confidential Table 16.11: T
- Page 253 and 254:
DRAFT - Confidential mechanisms to
- Page 255 and 256:
DRAFT - Confidential Table 16.16: S
- Page 257 and 258:
DRAFT - Confidential Table 16.19: T
- Page 259 and 260:
DRAFT - Confidential Given the cons
- Page 261 and 262:
DRAFT - Confidential month follow-u